Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy

International Journal of Artificial Organs

Volumn 27, Issue 11, 2004, Pages 918-923

  Spasovski, Goce B ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Bone biopsy; Renal failure; Renal osteodystrophy

Indexed keywords

ALUMINUM COATINGS; BONE; CELLS; CLINICAL RESEARCH; DIALYSIS;

BONE BIOPSY; BONE CELLS; BONE MARKERS; BONE TURNOVER; DIAGNOSTICS TOOLS; HOMOEOSTASIS; RENAL DISEASE; RENAL FAILURE; RENAL OSTEODYSTROPHY; VITAMIN-D;

DISEASES;

ALUMINUM; CALCIUM; DEMECLOCYCLINE; PARATHYROID HORMONE; PHOSPHORUS; STRONTIUM; TETRACYCLINE;

BONE BIOPSY; BONE CELL; BONE MALFORMATION; BONE MINERALIZATION; BONE PAIN; BONE STRUCTURE; BONE TURNOVER; CALCIUM BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DOSE KIDNEY FUNCTION RELATION; EDITORIAL; FLUORESCENCE ANALYSIS; FRACTURE; HEMATOMA; HUMAN; KIDNEY FAILURE; MINERAL METABOLISM; MORBIDITY; MORPHOMETRICS; NEUROPATHY; PAIN; PARATHYROID HORMONE BLOOD LEVEL; RENAL OSTEODYSTROPHY; SAFETY; STAINING; SURVIVAL RATE; VITAMIN D METABOLISM; WOUND INFECTION;

EID: 12544257882     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701103     Document Type: Editorial

References (22)

1. Llach F, Coburn JW. Renal osteodystrophy and maintenance dialysis. In: Maher JF, ed. Replacement of renal function by dialysis. Dordrecht/Boston/Lancaster: Kluwer Academic Publishers, 1989: pp. 911-52.
2. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43: 436-42.
3. Faugere MC, Malluche HH. Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients. Kidney Int 1986; 30: 717-22.
4. Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 1995; 310: 358-63.
5. Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, Couttenye MM, De Broe ME, D'Haese PC. Spectrum of renal bone disease in end-stage renal failure patients not on dialysis yet. Nephrol Dial Transplant 2003; 18: 1159-66.
6. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 1988; 33: 975-82.
7. Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 1065-72.
8. Hernandez D, Concepcion MT, Lorenzo V, Martinez ME, Rodriguez A, De Bonis E, Gonzalez-Posada JM, Felsenfeld AJ, Rodriguez M, Torres A. Adynamic bone disease with negative aluminum staining in predialysis patients: Prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 1994; 9: 517-23.
9. Rix M, Andreassen H, Eskildsen P, et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56: 1084-93.
10. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, Gokal R. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-7.
11. Urena P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55: 2141-56.
12. Malluche H, Faugere MC. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211.
13. Hodgson S, Johnson K, Muhs J, et al. Outpatient percutaneous biopsy of the iliac crest. Mayo Clin Proc 1986; 61: 28-33.
14. D'Haese PC, Van de Vyver FL, de Wolff FA, De Broe ME. Measurement of aluminum in serum, blood, urine, and tissues of chronic hemodialyzed patients by use of electrothermal atomic absorption spectrometry. Clin Chem 1985; 31: 24-9.
15. D'Haese PC, Van Landeghem GF, Lamberts LV, Bekaert VA, Schrooten I, De Broe ME. Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometry. Clin Chem 1997; 43: 121-8.
16. De Broe ME, Yawalkar SJ, Abreo K. Desferall® (desferrioxamine) in dialysis patients with aluminium overload. Basel, Switzerland: Ciba-Geigy Limited, 1993: pp. 22-34.
17. Duncan H, Rao S, Parfitt A. Complications of bone biopsies. Metab Bone Dis Relat Res 1980; 2: 475-81.
18. Moniere-Faugere MC, Langub MC, Malluche HH. Mineralized bone histology in normal and uremic states. In: Bushinsky DA, ed. Renal osteodystrophy. Philadelphia: Lippincott-Raven 1998. pp. 49-87.
19. Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA. Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 2000; 58: 1440-9.
20. Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis ESRF. Am J Kidney Dis 2003; 41: 997-1007.
21. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM, et al. Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-42.
22. D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME. Multi-centre study on the effects of lanthanum carbonate (Fosrenol®) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 2003; 63 (suppl): S73-8.